Belgium· BE-AMP-SAM061862-00
Dalacin C 75 mg/5 ml
A clindamycin product containing clindamycin palmitate hydrochloride, registered in Belgium by Pfizer. The same ATC class is registered in 15 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Clindamycin is registered in 15 of 19 countries.
Countries holding a registration under ATC J01FF01 (clindamycin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Clindamycin · ATC J01FF01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of clindamycin costs, country by country.
Normalised to the WHO defined daily dose (1.2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Clindamycin · price per daily dose (1.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$9.84
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Clindamycin Palmitate Hydrochloride
- Manufacturer
- Pfizer
- Country
- Belgium (BE)
- ATC code
- J01FF01
- ATC class
- Clindamycin
- Defined daily dose
- 1.2 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0030916
- be_apb0704031
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
378 interactions on record for clindamycin.
Graded by severity as the source publishes them — 72 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Clindamycin · interactions on record
378 records
- 72 moderate
- 2 minor
- 304 info
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- KaolinA07BC02moderate
- AttapulgiteA07BC04moderate
- BalsalazideA07EC04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Clindamycin in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- United Kingdom (Northern Ireland) · Clindamycin Penlan Pharmaceuticals
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/724d56d2-285b-4f17-83d6-0a9b0832e9fa GET /v1/drugs/724d56d2-285b-4f17-83d6-0a9b0832e9fa?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Granules for oral suspension",
"source": "afmps",
"status": "REVOKED",
"name_en": "Dalacin C 75 mg/5 ml",
"name_fr": "Dalacin C 75 mg/5 ml",
"name_nl": "Dalacin C 75 mg/5 ml",
"amp_code": "SAM061862-00",
"strengths": [
"24.7060",
"24.7060",
"15.0000",
"15.0000",
"0.6000",
"1.8000"
],
"pack_count": 7,
"substances": [
"Clindamycin Palmitate Hydrochloride",
"Clindamycin",
"Ethyl Parahydroxybenzoate",
"Sucrose"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Clindamycin",
"authorisation_numbers": [
"BE061862"
]
}See everything about clindamycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.